+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statin discontinuation: counterbalancing the benefits with the potential risks



Statin discontinuation: counterbalancing the benefits with the potential risks



Archives of Medical Science 7(6): 1076-1077




(PDF emailed within 0-6 h: $19.90)

Accession: 055911066

Download citation: RISBibTeXText

PMID: 22328893

DOI: 10.5114/aoms.2011.26622


Related references

Misperception among physicians and patients regarding the risks and benefits of statin treatment: the potential role of direct-to-consumer advertising. Journal of Clinical Lipidology 2(1): 51-57, 2008

Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study). Turk Kardiyoloji Dernegi Arsivi 44(1): 53-64, 2016

Statins: the high risks of discontinuation and large benefits of continuation. Archives of Medical Science 7(6): 931-932, 2012

Safety and statin therapy: reconsidering the risks and benefits. Archives of Internal Medicine 163(6): 657-659, 2003

Risks and benefits of continued aggressive statin therapy. Clinical Cardiology 26(4 Suppl 3): Iii3-Ii12, 2003

Benefits and Risks of Statin Therapy in the HIV-Infected Population. Current Infectious Disease Reports 20(8): 20, 2018

What you should know about statin side effects. The benefits of these drugs far outweigh the risks. Heart Advisor 13(6): 5-5, 2013

Risks and benefits of statin use in young people with type 1 diabetes. Current Diabetes Reports 14(7): 499, 2014

Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation. General Dentistry 60(4): 255-258, 2013

Statin treatment non-adherence and discontinuation: clinical implications and potential solutions. Current Pharmaceutical Design 20(40): 6314-6324, 2015

Rest easy, statin users. Benefits dwarf risks for these cholesterol drugs. U.S. News and World Report 131(8): 45, 2001

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet 380(9841): 565-571, 2012

Treatment of statin adverse effects with supplemental Coenzyme Q10 and statin drug discontinuation. Biofactors 25(1-4): 147-152, 2006

Balancing chemical and microbial risks of drinking water disinfection, Part I. Benefits and potential risks. Aqua 43(4): 192-199, 1994

Predictors of Statin Adherence, Switching, and Discontinuation in the USAGE Survey Understanding Statin Use in America and Gaps in Patient Education. Journal of Clinical Lipidology 7(3): 245-246, 2013